Annual report
4360.TEDINET S100R3ZN
Period2022-04-01 → 2023-03-31
Filed2023-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 22 passed
Key figures · 72
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥10.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥991m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥740m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥881m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥940m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥712m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥821m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥712m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥15.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥13.6bn | at 2022-03-31 | Cons. | Assets |
| Total liabilities | ¥4.0bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥3.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.3bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.8bn | at 2021-03-31d | Cons. | Net assets |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.0bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.7bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥714m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥199m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥422m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥125m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥200m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥103.26 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.52 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,384.71 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,300.81 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 73.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.7% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 236 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 241 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥672m | 2022-04-01 → 2023-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥317m | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Operating income | ¥375m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥173m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥760m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥188m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | ¥814m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥242m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥662m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥174m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Total assets | ¥11.2bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥10.6bn | at 2022-03-31 | Standalone | Assets |
| Total liabilities | ¥165m | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥79m | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥11.1bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥10.5bn | at 2022-03-31 | Standalone | Net assets |
| Cash and deposits | ¥1.5bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥700m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥83.29 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.05 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥15 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7.5 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,388.88 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,324.77 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 98.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.2% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.7% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,625,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,625,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Employees | 8 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 7 | at 2022-03-31 | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥91m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥117m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥6.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥1.1bn |
| Fine Chemical Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥62m |
| Fine Chemical Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥218m |
| Fine Chemical Businessreportable segment | employees | at 2023-03-31 | 96 pure |
| Fine Chemical Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.3bn |
| Fine Chemical Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.3bn |
| Fine Chemical Businessreportable segment | segment assets | at 2023-03-31 | ¥4.9bn |
| Fine Chemical Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥768m |
| Flame Retardants Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥101m |
| Flame Retardants Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥120m |
| Flame Retardants Businessreportable segment | employees | at 2023-03-31 | 47 pure |
| Flame Retardants Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥6.2bn |
| Flame Retardants Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥6.2bn |
| Flame Retardants Businessreportable segment | segment assets | at 2023-03-31 | ¥3.1bn |
| Flame Retardants Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Health Support Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥31m |
| Health Support Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥31m |
| Health Support Businessreportable segment | employees | at 2023-03-31 | 14 pure |
| Health Support Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Health Support Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Health Support Businessreportable segment | segment assets | at 2023-03-31 | ¥845m |
| Health Support Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥31m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥195m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥369m |
| —segment total | employees | at 2023-03-31 | 157 pure |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥11.9bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥11.9bn |
| —segment total | segment assets | at 2023-03-31 | ¥8.9bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥70m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥107m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥4.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥1.0bn |
| Fine Chemical Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥316m |
| Fine Chemical Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥200m |
| Fine Chemical Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.5bn |
| Fine Chemical Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.5bn |
| Fine Chemical Businessreportable segment | segment assets | at 2022-03-31 | ¥5.0bn |
| Fine Chemical Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥637m |
| Flame Retardants Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥196m |
| Flame Retardants Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥113m |
| Flame Retardants Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.0bn |
| Flame Retardants Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.0bn |
| Flame Retardants Businessreportable segment | segment assets | at 2022-03-31 | ¥2.9bn |
| Flame Retardants Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥993m |
| Health Support Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥80m |
| Health Support Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥29m |
| Health Support Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Health Support Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Health Support Businessreportable segment | segment assets | at 2022-03-31 | ¥773m |
| Health Support Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥158m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥593m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥343m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥10.7bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥10.7bn |
| —segment total | segment assets | at 2022-03-31 | ¥8.6bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,263
| Item | Context | Value | Unit |
|---|---|---|---|
| Loss gain on sales and retirement of property plant and equipment ope cf | CurrentYearDuration | -52000000 | JPY |
| Impairment loss ope cf | Prior1YearDuration | － | JPY |
| Impairment loss ope cf | CurrentYearDuration | 152000000 | JPY |
| Subsidy income2 ope cf | Prior1YearDuration | -28000000 | JPY |
| Subsidy income2 ope cf | CurrentYearDuration | -69000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | -630000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | 503000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | -78000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | -1214000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | 488000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | 435000000 | JPY |
| Other net ope cf | Prior1YearDuration | -27000000 | JPY |
| Other net ope cf | CurrentYearDuration | 404000000 | JPY |
| Subtotal ope cf | Prior1YearDuration | 969000000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 1685000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration | 43000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 42000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration | -1000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -1000000 | JPY |
| Income taxes paid ope cf | Prior1YearDuration | -324000000 | JPY |
| Income taxes paid ope cf | CurrentYearDuration | -148000000 | JPY |
| Proceeds from subsidy income2 ope cf | Prior1YearDuration | 28000000 | JPY |
| Proceeds from subsidy income2 ope cf | CurrentYearDuration | 69000000 | JPY |
| Net cash provided by used in operating activities | Prior1YearDuration | 714000000 | JPY |
| Net cash provided by used in operating activities | CurrentYearDuration | 1647000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YearDuration | -684000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYearDuration | -250000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YearDuration | 1000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYearDuration | 251000000 | JPY |
| Purchase of investment securities inv cf | Prior1YearDuration | -221000000 | JPY |
| Purchase of investment securities inv cf | CurrentYearDuration | -0 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YearDuration | 288000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYearDuration | 200000000 | JPY |
| Proceeds from cancellation of money held in trust inv cf | Prior1YearDuration | 200000000 | JPY |
| Proceeds from cancellation of money held in trust inv cf | CurrentYearDuration | － | JPY |
| Other net inv cf | Prior1YearDuration | -5000000 | JPY |
| Other net inv cf | CurrentYearDuration | -1000000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -422000000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | 199000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YearDuration | -20000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYearDuration | 1000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -18000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -1000000 | JPY |
| Repayments of finance lease obligations fin cf | Prior1YearDuration | -24000000 | JPY |
| Repayments of finance lease obligations fin cf | CurrentYearDuration | -5000000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -137000000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -119000000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -200000000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -125000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | 0 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 22 of 22 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |